多西他赛在Ⅱb期以上宫颈癌同步放化疗的疗效与不良反应与顺铂的对比(1)
【摘要】目的:分析多西他赛与顺铂在Ⅱb期以上宫颈癌同步放化疗的疗效与不良反应。方法:以2017年1月-2019年1月间入本院治疗的69例Ⅱb期以上宫颈癌患者为研究主体。分成A组和B组,分别是36例与33例。A组给予多西他赛同步放化疗,B组给予顺铂同步放化疗。对比疗效与安全性。结果:A组的治疗总有效率为86.11%,B组为81.82%(P>0.05)。A组的不良反应发生率为13.89%,B组为39.39%(P<0.05)。结论:为该病患者行以上两种治疗方案的疗效相当,但多西他赛同步放化疗的安全性更佳,更具临床应用价值。【关键词】多西他赛;顺铂;Ⅱb期宫颈癌;同步放化疗;不良反应
【中图分类号】R197.3 【文献标识码】B 【文章编号】1672-3783(2018)11-0243-01
【Abstract】Objective:
to analyze how his game and cisplatin in Ⅱ b period more than cervical cancer chemoradiation curative effect and adverse reactions.Methods: in January 2017 - January 2019 in our hospital between treatment of 69 cases of Ⅱ b period more than cervical cancer patients as the research subject.There were 36 cases in group A and 33 cases in group B.Docetaxel was given concurrent chemoradiotherapy in group A ......
您现在查看是摘要页,全文长 3316 字符。